Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1375, 2003-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ropinirole warranted versus levodopa/benserazide in PD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 400, 2003-01 ,pp. :
Access to resources
Recommend
Levodopa/benserazide withdrawal: First report of dystonia: case report
Reactions Weekly, Vol. 1, Iss. 1050, 2005-01 ,pp. :
Cost Analysis of Ropinirole versus Levodopa in the Treatment of Parkinson's Disease
By Iskedjian M.
PharmacoEconomics, Vol. 21, Iss. 2, 2003-01 ,pp. :
By Kulisevsky Jaime Pagonabarraga Javier
Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. :
Levodopa/ropinirole: Dopamine dysregulation syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1314, 2010-01 ,pp. :